Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Reuters

07:22 EDT 18th October 2017 | BioPortfolio

Here are the most relevant search results for "Reuters" found in our extensive news archives from over 250 global news sources.

More Information about Reuters on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reuters for you to read. Along with our medical data and news we also list Reuters Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reuters Companies for you to search.

Showing News Articles 1–25 of 3,100+ from Reuters

Wednesday 18th October 2017

Senate backers of deal to stabilize Obamacare seek to build support

WASHINGTON (Reuters) - Proponents of a bipartisan deal struck by two U.S. senators to stabilize Obamacare were seeking on Wednesday to win Republican support for the measure, which would restore subsidies to health insurers that President Donald Trum...

Tuesday 17th October 2017

Astra and Merck win speedy review for Lynparza in breast cancer

LONDON (Reuters) - U.S. regulators have granted a priority review to AstraZeneca's ovarian cancer drug Lynparza as a treatment for breast cancer, putting it on track for potential approval in the new disease area during the first quarter of 2018.

McDonald's South Korea office raided in burger probe: reports

SEOUL (Reuters) - South Korean investigators raided the Seoul office of McDonald's Corp on Wednesday, following a series of complaints that children fell ill after eating hamburger patties alleged to have been undercooked, Yonhap News Agency and othe...

Novartis says ‍revolade shows long-term disease control for chronic/persistent immune thrombocytopenia​

ZURICH (Reuters) - Novartis said on Wednesday a long term study of ‍its Revolade drug showed good results in treating chronic and persistent immune thrombocytopenia (ITP) - a condition where patients' blood does not clot normally.

Frailty tied to higher risk of complications with common surgeries

(Reuters Health) - Frail patients are more likely to have serious complications after elective outpatient surgery than people who are healthier and stronger, a recent study suggests.

New cancer drugs help Johnson & Johnson top profit estimates

(Reuters) - Johnson & Johnson posted better-than-expected third-quarter earnings, raising its full-year forecast due to growth from new cancer drugs and high-margin treatments picked up in its $30 billion acquisition of Actelion earlier this year.

Florida needs more pet-friendly hurricane shelters for the elderly

(Reuters Health) - When pet owners need to flee from disasters like hurricanes and fires, they often think first of their animals, but a new study suggests a scarcity of pet-friendly emergency shelters could make older evacuees all the more vulnerabl...

Allergan ruling casts doubt on tribal patent strategy

(Reuters) - A U.S. judge’s ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patent...

J&J wins reversal of $72 million verdict over talc cancer risks

(Reuters) - Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.

Transenterix won't compete head-on with Intuitive Surgical: CEO

(Reuters) - Transenterix Inc's chief executive played down on Tuesday the threat posed by his company's surgical robotic system to market leader Intuitive Surgical Inc, saying he did not expect the two to compete head on.

UnitedHealth sees growth in 2018, a year of changes by Trump

(Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer,

Should donor sex influence blood transfusion practices?

(Reuters Health) - Sick or injured men who receive blood transfusions may be more likely to die if their donor was a woman who has been pregnant in the past, a new study suggests.

Drugmakers Amneal, Impax to combine in generics push

(Reuters) - Amneal Pharmaceuticals LLC is buying peer Impax Laboratories Inc in an all-stock deal as it looks to add heft to its generics business and gain an edge in a tough drug pricing environment.

UnitedHealth sees growth in 2018, opportunities in Trump plans

(Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, said earnings will grow 13 to 16 percent in 2018 as medical costs remain low, and that it expects to benefit from new insurance products backed by U.S. President Donald Trump.

Johnson & Johnson wins reversal of $72 million verdict over talc cancer risks

(Reuters) - Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.

Fatty liver disease fastest-growing reason for transplants in young U.S. adults

(Reuters Health) - Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplants in young Americans, according to a recent study.

China confirms bird flu outbreak at poultry farms in central province

BEIJING (Reuters) - China on Tuesday confirmed an outbreak of bird flu at broiler chicken farms in a central province, the Ministry of Agriculture said in a statement.

Trump's drug czar nominee withdraws from consideration

WASHINGTON (Reuters) - President Donald Trump's pick for U.S. drug czar withdrew on Tuesday after it become public that he spearheaded a bill that undercut the government's power to crack down on opioid makers that were flooding the market with the a...

U.S. indicts two Chinese in major fentanyl trafficking case

WASHINGTON (Reuters) - The U.S. Department of Justice said on Tuesday it has indicted two major Chinese drug traffickers on charges of making and selling highly addictive fentanyl to Americans over the internet.

New cancer drugs help J&J top profit estimates

(Reuters) - Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast as the company gained from strong sales of its new cancer drugs.

Japan's "Blade Library" offers joy of blade running to amputees

TOKYO (Reuters) - Haruta Saito, a young Japanese amputee who dreams of becoming a Paralympian, remembers strapping on a prosthetic "running blade" for the first time.

Monday 16th October 2017

Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors

LONDON (Reuters) - An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines.

Regeneron-Sanofi drug succeeds mid-stage study

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.

Intensive resistance training safe, effective for women with osteoporosis

(Reuters Health) - High-intensity resistance and impact training (HiRIT) may improve bone and muscle strength in select postmenopausal women with osteoporosis, according to a small study in Australia.

More men than women infected with oral human papillomavirus

(Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests.


Quick Search
Advertisement
 

News Quicklinks